CDK1 and acute myeloid leukemia: As an example, multi-drug resistance in AML was reported to correlate with low levels of EZH2 expression due to Cyclin Dependent Kinase 1 (CDK1) and Heat Shock Protein 90 (HSP90) mediated proteasomal degradation.